Adrian N. Hobden
2007 - Myriad Genetics
In 2007, Adrian N. Hobden earned a total compensation of $1.2M as President, Myriad Pharmaceuticals, Inc at Myriad Genetics.
Compensation breakdown
| Bonus | $300,761 |
|---|---|
| Option Awards | $378,292 |
| Salary | $465,478 |
| Other | $9,440 |
| Total | $1,153,971 |
Hobden received $465.5K in salary, accounting for 40% of the total pay in 2007.
Hobden also received $300.8K in bonus, $378.3K in option awards and $9.4K in other compensation.
Rankings
In 2007, Adrian N. Hobden's compensation ranked 3,694th out of 8,700 executives tracked by ExecPay. In other words, Hobden earned more than 57.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,694 out of 8,700 | 58th |
Division Manufacturing | 1,309 out of 3,314 | 61st |
Major group Chemicals And Allied Products | 256 out of 746 | 66th |
Industry group Drugs | 143 out of 546 | 74th |
Industry In Vitro and In Vivo Diagnostic Substances | 6 out of 45 | 87th |
Source: SEC filing on October 15, 2007.
Hobden's colleagues
We found four more compensation records of executives who worked with Adrian N. Hobden at Myriad Genetics in 2007.